RVL Pharmaceuticals Market Cap

RVL Pharmaceuticals has a market cap or net worth of $111.00 as of December 27, 2024. Its market cap has decreased by -100.00% in one year.

Market Cap

111.00

Enterprise Value

38.99M

Revenue

36.92M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.00

Market Cap Chart

Since October 18, 2018, RVL Pharmaceuticals's market cap has decreased from 419.90M to 111.00, a decrease of -100.00%. That is a compound annual growth rate of -91.33%.

Market Cap History

Date	Market Cap	% Change
Dec 26, 2024	111.00	-99.97%
Dec 29, 2023	334.22K	-99.70%
Dec 30, 2022	111.05M	23.46%
Dec 31, 2021	89.95M	-65.11%
Dec 31, 2020	257.85M	-28.96%
Dec 31, 2019	362.96M	-10.82%
Dec 31, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Sandoz Group AG	18.07B
Telix Pharmaceuticals Limited	5.20B
Elekta AB (publ)	2.09B
Ryman Healthcare Limited	1.72B
Verano Holdings Corp.	463.76M
Vireo Growth Inc.	129.65M
Medexus Pharmaceuticals Inc.	55.68M

Market Cap Rankings